bpc-157 clinical trials 2025 BPC-157: What the Science Says (Zero Human Trials) BPC-157: The peptide with big

Tirzepatide (with Pyridoxine) : Tirzepatide is a dual agonist at GIP and GLP1 receptors, originally developed for type 2 diabetes, and is now widely used for significant, clinically meaningful weight loss and metabolic health improvements

"The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration." Journal of Applied Physiology

PMID: 40935835 Cheng J et al

Peptides are short chains of amino acids that act as signaling molecules in the body, instructing cells to perform specific functions such as collagen production, fat metabolism, or muscle repair